The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Vir Biotechnology Inc shares valued at $2,501,785 were sold by SVF Endurance (Cayman) Ltd on Oct 03 ’25. At $5.56 per share, SVF Endurance (Cayman) Ltd sold 450,342 shares. The insider’s holdings dropped to 16,233,699 shares worth approximately $98.21 million following the completion of this transaction.
Also, SVF Endurance (Cayman) Ltd sold 73,955 shares, netting a total of over 420,641 in proceeds. Following the sale of shares at $5.69 each, the insider now holds 16,159,744 shares.
Before that, SVF Endurance (Cayman) Limited had added 1,668,404 shares to its account. In a trade valued at $9,526,587, the 10% Owner bought Vir Biotechnology Inc shares for $5.71 each.
As published in their initiating research note from Evercore ISI on September 03, 2025, Vir Biotechnology Inc [VIR] has been an Outperform and the price target has been revised to $12. Analysts at BofA Securities upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late August. As of January 29, 2024, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for VIR. Earlier on September 08, 2023, BofA Securities downgraded its rating. Their new recommendation was “a Neutral” for VIR stock which previously was a “a Buy”.
Analyzing VIR Stock Performance
On last trading session, Vir Biotechnology Inc [NASDAQ: VIR] rose 6.89% to $6.05. The stock’s lowest price that day was $5.61, but it reached a high of $6.33 in the same session. During the last five days, there has been a surge of approximately 6.14%. Over the course of the year, Vir Biotechnology Inc shares have dropped approximately -21.83%. Shares of the company reached a 52-week high of $14.45 on 01/08/25 and a 52-week low of $4.16 on 08/11/25.
Support And Resistance Levels for Vir Biotechnology Inc (VIR)
According to the 24-hour chart, there is a support level at 5.66, which, if violated, would cause prices to drop to 5.28. In the upper region, resistance lies at 6.38. The next price resistance is at 6.72. RSI (Relative Strength Index) is 68.37 on the 14-day chart, showing neutral technical sentiment.
Is Vir Biotechnology Inc subject to short interest?
Stocks of Vir Biotechnology Inc saw a sharp rise in short interest on 2025-09-15 jumping by 0.37 million shares to 11.85 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 11.49 million shares. A jump of 3.08% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.76 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.76.
Which companies own the most shares of Vir Biotechnology Inc (VIR)?
In terms of Vir Biotechnology Inc share price expectations, FactSet research, analysts set an average price target of 12 in the next 12 months, up nearly 112.01% from the previous closing price of $5.66. Analysts anticipate Vir Biotechnology Inc stock to reach 12 by 2025, with the lowest price target being 12. In spite of this, 10 analysts ranked Vir Biotechnology Inc stock as Buy at the end of 2025. On March 06, 2023, JP Morgan assigned a price target of “an Overweight” to the stock and upgraded coverage with a $34.
